X

Select your destination

This is Radiometer Medical's global website and may contain information on products not released in all markets.
For information on products and services in your local market, please proceed to your local Radiometer website.

Continue to Radiometer Medical

Radiometer has joined the fight against sepsis, providing a rapid, acute care testing solution for procalcitonin (PCT)

Radiometer joins the fight against sepsis

Radiometer, a leading provider of acute care testing solutions, is helping to promote awareness of the importance of early diagnosis of sepsis, a global medical emergency affecting over 20 million people every year

September 8, 2015

Symptoms are often unclear and unspecific, making diagnosis extremely challenging. As a result, the condition is often overlooked or recognized too late, with devastating consequences; 30 percent or more of patients who develop sepsis die.

As World Sepsis Day on September 13 approaches, Radiometer is highlighting the importance of identifying the condition and initiating appropriate antibiotic treatment at the earliest opportunity. Its broad portfolio of acute care tests provides healthcare professionals with vital tools to monitor key diagnostic and prognostic markers for sepsis, including glucose, bilirubin, lactate, white blood cells, C­reactive protein, creatinine and blood gas. These tests are perfectly complemented by Radiometer’s recently launched procalcitonin (PCT) assay, enabling early and convenient measurement of PCT – the biomarker of choice to aid the diagnosis of sepsis – with results available to treating physicians in less than 21 minutes.

Rapid point-of-care testing significantly improves turnaround times, empowering clinicians to diagnose sepsis sooner, because the earlier sepsis is detected, the better the odds for a full recovery.

To find out more, please contact Radiometer or visit www.radiometer.com/sepsisdetection.

Cookies are used on this website

Use of cookies